• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美敦力公司生产的 24 毫米经导管肺动脉瓣植入后工作正常。

The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter--it works.

机构信息

The Heart Center, Nationwide Children's Hospital, Columbus, Ohio.

出版信息

Catheter Cardiovasc Interv. 2013 Nov 1;82(5):816-23. doi: 10.1002/ccd.24821. Epub 2013 Aug 12.

DOI:10.1002/ccd.24821
PMID:23359563
Abstract

OBJECTIVES

We report the Melody valve implanted and/or expanded to 24-mm diameter.

BACKGROUND

The Medtronic Melody valve has been implanted up to 22 mm in the pulmonary position for over a decade.

METHODS

A retrospective chart review was performed on 82 patients who underwent Melody valve implant. Technical implant method, pre- and postimplant echocardiographic findings, and initial follow-up were reviewed.

RESULTS

Between 04/2008 and 12/2011, 13 Melody valves were successfully implanted in 11 patients, median age 35 years (range 16-61 years), in the pulmonary (bioprosthetic valve, right ventricle to pulmonary artery conduit, native valve) position (n = 9), tricuspid position (bioprosthetic valve n = 3), and aortic position (bioprosthetic valve n = 1). Ten valves were delivered on a 24-mm balloon in balloon catheter and three were implanted using a 22-mm Ensemble balloon delivery system, followed by postdilation using a 24-mm × 2-cm Atlas balloon catheter. Postimplant, the median peak systolic gradient across the pulmonary valve was 7 mm Hg and median gradient across the tricuspid valve was 3 mm Hg. There was no change in gradient across the Melody valve in the aortic position where valve prosthesis-patient mismatch was present. Postimplant intracardiac echocardiography demonstrated none or mild valve regurgitation. No more than mild regurgitation was noted at a median follow-up of 9.5 months.

CONCLUSIONS

The Melody valve can be implanted at 24 mm in the stenotic/regurgitant bioprosthetic pulmonary, tricuspid, and aortic valve, dysfunctional right ventricle to pulmonary artery conduit, and the native right ventricular outflow tract, whereas the valve remains competent with only mild regurgitation.

摘要

目的

我们报告了经扩张至 24mm 直径的 Melody 瓣膜植入和/或扩张情况。

背景

十余年来,美敦力(Medtronic)Melody 瓣膜已被植入肺动脉瓣位置,最大直径为 22mm。

方法

对 82 例行 Melody 瓣膜植入术的患者进行回顾性图表审查。回顾了技术植入方法、植入前后的超声心动图结果和初始随访情况。

结果

2008 年 4 月至 2011 年 12 月,11 名患者(中位年龄 35 岁,范围 16-61 岁)成功植入 13 枚 Melody 瓣膜,植入部位包括肺动脉瓣(生物瓣、右心室至肺动脉导管、原生瓣)(n=9)、三尖瓣(生物瓣 n=3)和主动脉瓣(生物瓣 n=1)。10 枚瓣膜采用 24mm 球囊输送,3 枚采用 22mm Ensemble 球囊输送系统植入,随后使用 24mm×2cm Atlas 球囊导管进行后扩张。植入后,肺动脉瓣的中位收缩期峰值跨瓣梯度为 7mmHg,三尖瓣的中位梯度为 3mmHg。主动脉瓣存在瓣周漏,因此瓣膜-患者不匹配,跨瓣梯度无变化。植入后,经心腔内超声心动图检查显示无或轻度瓣周漏。中位随访 9.5 个月时,瓣周漏仅为轻度。

结论

Melody 瓣膜可植入狭窄/反流性生物瓣肺动脉瓣、三尖瓣和主动脉瓣、功能不良的右心室至肺动脉导管以及原生右心室流出道,而瓣膜仍保持功能正常,仅存在轻度反流。

相似文献

1
The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter--it works.美敦力公司生产的 24 毫米经导管肺动脉瓣植入后工作正常。
Catheter Cardiovasc Interv. 2013 Nov 1;82(5):816-23. doi: 10.1002/ccd.24821. Epub 2013 Aug 12.
2
One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.Melody 经导管肺动脉瓣多中心上市后研究的一年随访结果。
JACC Cardiovasc Interv. 2014 Nov;7(11):1254-62. doi: 10.1016/j.jcin.2014.08.002. Epub 2014 Nov 17.
3
Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience.在肺动脉位置失败的生物瓣中植入 melody 瓣膜:一项多中心经验。
Circ Cardiovasc Interv. 2012 Dec;5(6):862-70. doi: 10.1161/CIRCINTERVENTIONS.112.972216. Epub 2012 Dec 4.
4
Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.经导管肺动脉瓣置换术使用 melody 瓣膜治疗功能性外科生物瓣衰败:一项多中心研究。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1712-1724.e1. doi: 10.1016/j.jtcvs.2017.10.143. Epub 2017 Dec 6.
5
Single-center comparative outcomes of the Edwards SAPIEN and Medtronic Melody transcatheter heart valves in the pulmonary position.经导管心瓣膜在肺动脉位置的爱德华 SAPIEN 和美敦力 Melody 单中心对比结果。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E535-41. doi: 10.1002/ccd.24680. Epub 2013 Mar 18.
6
Percutaneous pulmonary Melody valve implantation in small conduits.经皮肺 Melody 瓣膜植入术在小管道中的应用。
Arch Cardiovasc Dis. 2017 Oct;110(10):517-524. doi: 10.1016/j.acvd.2016.12.013. Epub 2017 May 23.
7
Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: Initial experience and development of a new delivery platform.经导管使用 Sapien XT 进行自体肺动脉瓣和三尖瓣置换:初步经验及新输送平台的研发
Catheter Cardiovasc Interv. 2016 Sep;88(3):434-43. doi: 10.1002/ccd.26398. Epub 2016 May 3.
8
Melody ® transcatheter pulmonary valve implantation: results from a French registry.美乐®经导管肺动脉瓣植入术:来自法国一项注册研究的结果。
Arch Cardiovasc Dis. 2014 Nov;107(11):607-14. doi: 10.1016/j.acvd.2014.10.001. Epub 2014 Nov 6.
9
Transcatheter melody valve placement in large diameter bioprostheses and conduits: What is the optimal "Landing zone"?经导管将美敦力瓣膜置于大口径生物假体和管道中:最佳“着陆区”是什么?
Catheter Cardiovasc Interv. 2015 Nov;86(5):E217-23. doi: 10.1002/ccd.25922. Epub 2015 Mar 30.
10
Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve.经导管再介入治疗先前植入的经导管肺动脉瓣功能障碍的结果。
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1529-1540. doi: 10.1016/j.jcin.2020.03.035.

引用本文的文献

1
Transcatheter Pulmonary Valve Implantation in Congenital Heart Diseases: Current Advances and Future Prospectives.先天性心脏病经导管肺动脉瓣植入术:当前进展与未来展望
Children (Basel). 2025 Apr 24;12(5):547. doi: 10.3390/children12050547.
2
Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies.经导管肺动脉瓣置换术:当前瓣膜技术综述
J Soc Cardiovasc Angiogr Interv. 2022 Sep 16;1(6):100452. doi: 10.1016/j.jscai.2022.100452. eCollection 2022 Nov-Dec.
3
Catheter-based Interventions in Tetralogy of Fallot Across the Lifespan.
法洛四联症全生命周期的导管介入治疗
CJC Pediatr Congenit Heart Dis. 2023 Sep 15;2(6Part A):339-351. doi: 10.1016/j.cjcpc.2023.09.005. eCollection 2023 Dec.
4
Transcatheter pulmonic valve implantation: Techniques, current roles, and future implications.经导管肺动脉瓣植入术:技术、当前作用及未来意义。
World J Cardiol. 2021 May 26;13(5):117-129. doi: 10.4330/wjc.v13.i5.117.
5
The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.先天性心脏病治疗未来对再生医学的实际需求。
Biomedicines. 2021 Apr 27;9(5):478. doi: 10.3390/biomedicines9050478.
6
Pulmonary Valve Replacement for Tetralogy of Fallot.法洛四联症的肺动脉瓣置换术
Methodist Debakey Cardiovasc J. 2019 Apr-Jun;15(2):122-132. doi: 10.14797/mdcj-15-2-122.
7
Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.肺动脉瓣疾病:病理学回顾与当前治疗选择
Curr Cardiol Rep. 2017 Sep 16;19(11):108. doi: 10.1007/s11886-017-0922-2.
8
Hybrid Surgery Options for Complex Clinical Scenarios in Adult Patients with Congenital Heart Disease: Three Case Reports.成人先天性心脏病复杂临床病例的杂交手术方案:三例报告
Front Surg. 2017 Feb 9;4:7. doi: 10.3389/fsurg.2017.00007. eCollection 2017.
9
Dysfunctional pulmonary artery conduit and co-existing large pseudoaneurysm: well-suited for a percutaneous approach with the Melody valve?功能失调的肺动脉导管及并存的巨大假性动脉瘤:是否适合采用Melody瓣膜进行经皮介入治疗?
Springerplus. 2016 Sep 15;5(1):1575. doi: 10.1186/s40064-016-3273-3. eCollection 2016.
10
Therapeutic Utilities of Pediatric Cardiac Catheterization.小儿心导管检查的治疗用途
Curr Cardiol Rev. 2016;12(4):258-269. doi: 10.2174/1573403x12666160301121253.